Truth about the COVID19 Response
Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine
Among 51 017 working-aged Cleveland Clinic employees, the bivalent coronavirus disease 2019 vaccine was 29% and 20% effective in preventing infection while the
Original link
Dr. Alexandra Herion-Caude PhD | Full Interview Inside | Planet Lockdown
This interview with geneticist Alexandra Herion-Caude covers the concerns surrounding the mRNA vaccines. She explains what is RNA and how some of the proposed technology is working. Some serious questions are raised. Dr. Herion-Caude
Original link
Vaccine resources | Steve Kirsch
Detailed video presenting a compelling case that the current gene-based vaccines have killed over 25,000 people while the FDA, CDC, and NIH look the other way and ignore all the safety signals. These vaccines should be withdrawn immediately. Discusses the suppression of approval of repurposed drugs that
Original link
Rate of SARS-CoV-2 Reinfection During an Omicron Wave in Iceland
This cohort study estimates the proportion of persons who became reinfected with SARS-CoV-2 during the Omicron wave in Iceland.
Original link
COVID Vaccines Should Not Be Required to Return to Campus, States the Association of American Physicians and Surgeons - AAPS | Association of American Physicians and Surgeons
Colleges and universities should allow students back to campus without requiring a COVID-19 vaccination, urges the Association of American Physicians and Surgeons (AAPS) in letters being sent to institutions of higher learning across the United States that are planning to impose such mandates. “Although, at first glance, the policy may seem prudent, it coerces students […]
Original link
COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room | The Lancet
Vaccine efficacy is generally reported as a relative risk reduction (RRR). It uses the relative risk (RR)—ie, the ratio of attack rates with and without a vaccine—which is expressed as 1–RR. Ranking by reported efficacy gives relative risk reductions of 95% for the Pfizer–BioNTech, 94% for the Moderna–NIH, 90% for the Gamaleya, 67% for the J&J, and 67% for the AstraZeneca–Oxford vaccines. However, RRR should be seen against the background risk of being infected and becoming ill with COVID-19, which varies between populations and over time. Although the RRR considers only participants who could benefit from the vaccine, the absolute risk reduction (ARR), which is the difference between attack rates with and without a vaccine, considers the whole population. ARRs tend to be ignored because they give a much less impressive effect size than RRRs: 1·3% for the AstraZeneca–Oxford, 1·2% for the Moderna–NIH, 1·2% for the J&J, 0·93% for the Gamaleya, and 0·84% for the Pfizer–BioNTech vaccines.
Original link
What We Know — And May Never Know — About COVID Vaccines • Children's Health Defense
The animated video, “COVID Vaccine Secrets,” walks viewers through a long list of questions about the COVID vaccines, including many for which we may never have answers.
Original link
Here's the COVID Vaccine Injury Report CDC Was Forced to Release
Centers for Disease Control and Prevention’s Vaccine Adverse Event Reporting System safety signal analysis for mRNA COVID-19 vaccines shows clear safety signals for death and a range of highly concerning thrombo-embolic, cardiac, neurological, hemorrhagic, hematological, immune-system and menstrual adverse events among U.S. adults.
Original link
Covid 19 Spike Genes Include an exact sequence of human-optimized nucleotides that were patented by Moderna in 2016
Original link
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant | NEJM
Original Article from The New England Journal of Medicine — Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Original link